Sanderling Venture Partners Iv Co Investment Fund Lp - Net Worth and Insider Trading

Sanderling Venture Partners Iv Co Investment Fund Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sanderling Venture Partners Iv Co Investment Fund Lp owns 2 companies in total, including Pacira BioSciences Inc (PCRX) , and Stereotaxis Inc (STXS) .

Click here to see the complete history of Sanderling Venture Partners Iv Co Investment Fund Lp’s form 4 insider trades.

Insider Ownership Summary of Sanderling Venture Partners Iv Co Investment Fund Lp

Ticker	Comapny	Transaction Date	Type of Owner
PCRX	Pacira BioSciences Inc	2013-01-24	10 percent owner
STXS	Stereotaxis Inc	2005-11-28	10 percent owner

Sanderling Venture Partners Iv Co Investment Fund Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sanderling Venture Partners Iv Co Investment Fund Lp Ownership Network

Ownership Network List of Sanderling Venture Partners Iv Co Investment Fund Lp

No Data

Ownership Network Relation of Sanderling Venture Partners Iv Co Investment Fund Lp

Sanderling Venture Partners Iv Co Investment Fund Lp Owned Company Details

What does Pacira BioSciences Inc do?

Who are the key executives at Pacira BioSciences Inc?

Sanderling Venture Partners Iv Co Investment Fund Lp is the 10 percent owner of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Operating Officer Daryl Gaugler , Chief Clinical Officer Jonathan Slonin , and CAO and General Counsel Kristen Marie Williams .

Pacira BioSciences Inc (PCRX) Insider Trades Summary

Over the past 18 months, Sanderling Venture Partners Iv Co Investment Fund Lp made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 12,186 shares made by Lauren Bullaro Riker , a net sale of 9,754 shares made by Jonathan Slonin , and a net sale of 7,052 shares made by Daryl Gaugler .

In summary, during the past 3 months, insiders sold 4,281 shares of Pacira BioSciences Inc (PCRX) in total and bought 20,976 shares, with a net purchase of 16,695 shares. During the past 18 months, 231,391 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 210,415 shares.

Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pacira BioSciences Inc Insider Transactions

No Available Data

Sanderling Venture Partners Iv Co Investment Fund Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Sanderling Venture Partners Iv Co Investment Fund Lp. You might contact Sanderling Venture Partners Iv Co Investment Fund Lp via mailing address: 400 South El Camino Real Ste 1200, San Mateo Ca 94402-1708.

Discussions on Sanderling Venture Partners Iv Co Investment Fund Lp

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.